LiveWire Ergogenics Welcomes Legendary Tennis Champion Jimmy Connors as Spokesman and Advisor

Anaheim, CA, July 24, 2018 (GLOBE NEWSWIRE) -- LiveWire Ergogenics, Inc. (OTC:LVVV) is pleased to announce that retired American world number one tennis player Jimmy Connors has joined the firm as Spokesman and Advisor. LiveWire Ergogenics focuses on special purpose real estate acquisitions and the licensing and management of fully-compliant turnkey production facilities for cannabis-based products and services.

"We welcome Jimmy to LiveWire Ergogenics, where he will be serving as both Spokesman and Advisor for the Company,” states Bill Hodson, LiveWire’s CEO and Chairman. “Jimmy’s wealth of knowledge in the sports and wellness industries will be especially important as we expand into our next phase of development. His decades-long standing as one of the most-recognized personalities in the global sports world will add a new level of credibility and exposure for our Company. Plus, Jimmy’s association with LiveWire will also support our efforts to set the Company apart in a fast-growing and still turbulent and disruptive industry, and to pursue our unique business model in several distinct and potentially very-profitable sectors in the cannabis industry."

Jimmy Connors is a legendary number 1 ranked tennis player, and is considered among the greatest in the history of the sport. From 1974 to 1977 he held the top ATP ranking for a then-record 160 consecutive weeks, and he held this ranking for a total of 268 weeks throughout his entire career. Even today Jimmy still holds three prominent Open Era Men's singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight  (five US Open, two Wimbledon, one Australian Open), three , and 17 .

“I am delighted to have the opportunity to join the LiveWire team,” shares Jimmy. “LiveWire is a well-managed company that has already made significant progress in establishing itself as a credible leader in the new and rapidly-forming cannabis industry. After using a CBD product to relieve my own muscle pain, I am particularly excited about cannabis’ medicinal capabilities. I am looking forward to learning more about what the industry and company can do, and being part of LiveWire’s growth going forward.”

For more information about LiveWire Ergogenics, visit , follow LiveWire Ergogenics on Twitter @livewireLVVV, or download a research report at .

About LiveWire Ergogenics, Inc.

LiveWire Ergogenics, Inc. (LVVV) specializes in identifying and monetizing current and future trends in the health and wellness industry. The Company is focused on acquiring and licensing specialized turnkey cannabis real estate locations and establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for human and veterinarian applications. This includes the establishing of its revolutionary testing and verification system of zero pesticide products for quality brands via its “7X Pure” Cannabis Dosing and Verification System, and development and licensing of high-quality cannabinoid-based products and services. The Company does not produce, sell or distribute products that are in violation of any Federal or States laws and only conducts business in certain jurisdictions where such operation is legal, and the appropriate permits have been obtained by the Company. The team at LiveWire Ergogenics has a passion for research and is committed to generating and implementing innovative ideas and producing high-quality products that satisfy an increasing demand in this fast-growing industry.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and actual events may differ considerably. Factors that may cause actual results to differ materially from any projections may include, without limitation, the Company’s inability to obtain additional financing, delays in the development of its products, the impact of significant government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.